Profiling the TRPV4 ankyrin repeat domain interactome and its disruption by neuromuscular disease-causing mutations
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2025.110991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Alexis K Loder und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: TRPV Cation Channels, Ankyrin Repeat, Neuromuscular Diseases, Mutation, Missense. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, European Molecular Biology Organization.
Abstract (Originalsprache)
The ankyrin repeat is one of the most abundant protein-protein interaction motifs in eukaryotes yet occurs in only a small number of ion channels. These channels are all members of the transient receptor potential (TRP) superfamily and contain prominent ankyrin repeat domains (ARDs) in their cytoplasmic N termini. In transient receptor potential vanilloid 4 (TRPV4), the importance of this domain has been highlighted by the finding that gain-of-function neuromuscular disease-causing missense mutations cluster on the ARD surface. Little is known currently about the extent of the TRPV4-ARD interactome, nor how it may be altered by disease-causing mutations. Here, we utilized a human proteome microarray to profile the ARD interactomes of WT and mutant TRPV4. Probing of the microarray with TRPV4WT-ARD revealed 78 interactors, including proteins related to ubiquitination and small GTPase signaling, such as the ubiquitin ligase NEDD4L and the RhoGEF ARHGEF10. In parallel experiments, we also identified the deubiquitinase OTUB2 as an interactor of the proximal N terminus. Comparison of the ARD interactomes of WT and mutant TRPV4 revealed 21 interactions affected by disease-causing mutations. Strikingly, one of these interactors, ARHGEF10, is also mutated in neuromuscular disease. Cell-based studies confirmed that ARHGEF10 exhibits a reduced capacity to coimmunoprecipitate with mutant TRPV4. Furthermore, calcium imaging studies demonstrated that ARHGEF10 overexpression suppressed TRPV4WT channel activity, but that this inhibition is abrogated by disease-causing mutations. Together, these findings provide insights into the functional roles of an ion channel ARD, as well as their disruption in disease, and offer a resource for future cell-based studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; De…
- Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA.
- Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA; Institute of Organic Chemistry & Macromolecular Chemistry (IOMC), Friedrich Schiller University, Jena, Germany; Cluster of…
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- European Molecular Biology Organization
- National Institutes of Health
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Loder, A. K., Kosmanopoulos, G. P., Aisenberg, W. H., Cox, E., Meeker, A. R., Blackshaw, S., Gaudet, R., Hellmich, U. A., McCray, B. A., Sumner, C. J., & Sullivan, J. M. (2026). Profiling the TRPV4 ankyrin repeat domain interactome and its disruption by neuromuscular disease-causing mutations. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110991
Vancouver
Loder AK, Kosmanopoulos GP, Aisenberg WH, Cox E, Meeker AR, Blackshaw S, et al. Profiling the TRPV4 ankyrin repeat domain interactome and its disruption by neuromuscular disease-causing mutations. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.110991
BibTeX
@article{Loder2026,
author = {Loder, Alexis K and Kosmanopoulos, Gage P and Aisenberg, William H and Cox, Eric and Meeker, Alexis R and Blackshaw, Seth and Gaudet, Rachelle and Hellmich, Ute A and McCray, Brett A and Sumner, Charlotte J and Sullivan, Jeremy M},
title = {Profiling the TRPV4 ankyrin repeat domain interactome and its disruption by neuromuscular disease-causing mutations},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2025.110991}
}
EUVIMED